Literature DB >> 10411859

New device for closure of muscular ventricular septal defects in a canine model.

Z Amin1, X Gu, J M Berry, J L Bass, J L Titus, M Urness, Y M Han, K Amplatz.   

Abstract

BACKGROUND: Repair of muscular ventricular septal defects (MVSDs) has always been challenging to the surgeon. Long-term morbidity and mortality are significantly increased if the defects are closed via left ventriculotomy or if they are associated with other complex congenital anomalies. The purpose of this study was to close MVSDs with the Amplatz ventricular septal defect device. This device is constructed from 0.004-in nitinol wire mesh filled with polyester fibers. It is retrievable, repositionable, self-centering, and of low profile. METHODS AND
RESULTS: MVSDs were created with the help of a sharp punch in 10 dogs. The location of the defects was anterior muscular (n=3), midmuscular (n=3), apical (n=3), and inlet muscular (n=1). The diameter of the defects ranged from 6 to 14 mm. All defects were closed in the catheterization laboratory. The device was placed with the help of transesophageal echocardiography and fluoroscopy. A 7F sheath was used to deploy the device from the right ventricular side in 8 and the left ventricular side in 2 dogs. Placement was successful in all animals. The complete closure rate was 30% (3/10) immediately after placement and 100% at 1-week follow-up. Pathological examination of the heart revealed complete endothelialization of the device in dogs killed after 3 months.
CONCLUSIONS: The Amplatz ventricular septal defect device appears highly efficacious in closing MVSDs. The advantages include a small delivery sheath, complete retrievability before release, and the fact that it is self-centering and self-expanding, thereby making it an attractive option in smaller children.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411859     DOI: 10.1161/01.cir.100.3.320

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

1.  Multicenter experience with perventricular device closure of muscular ventricular septal defects.

Authors:  E A Bacha; Q L Cao; M E Galantowicz; J P Cheatham; C E Fleishman; S W Weinstein; P A Becker; S L Hill; P Koenig; E Alboliras; R Abdulla; J P Starr; Z M Hijazi
Journal:  Pediatr Cardiol       Date:  2005 Mar-Apr       Impact factor: 1.655

2.  Retrograde approach for device closure of muscular ventricular septal defects in children and adolescents, using the Amplatzer muscular ventricular septal defect occluder.

Authors:  Al-Ata Jameel; Amin Muhammed Arfi; Hussain Arif; Kouatli Amjad; Galal Mohammed Omar
Journal:  Pediatr Cardiol       Date:  2006-11-07       Impact factor: 1.655

3.  Perventricular device closure of isolated muscular ventricular septal defect in infants: a single centre experience.

Authors:  Bhavesh Thakkar; Nehal Patel; Shaunak Shah; Vishal Poptani; Tarun Madan; Chirag Shah; Anand Shukla; Vaishali Prajapati
Journal:  Indian Heart J       Date:  2012-09-12

4.  Perventricular closure of muscular ventricular septal defects: How do I do it?

Authors:  Karim A Diab; Qi-Ling Cao; Ziyad M Hijazi
Journal:  Ann Pediatr Cardiol       Date:  2008-01

5.  Teaching the "hybrid approach": a novel swine model of muscular ventricular septal defect.

Authors:  A B M Phillips; J Green; V Bergdall; J Yu; G Monreal; M Gerhardt; J P Cheatham; M Galantowicz; R J Holzer
Journal:  Pediatr Cardiol       Date:  2008-08-19       Impact factor: 1.655

6.  Efficacy and Safety of Using Amplatzer Ductal Occluder for Transcatheter Closure of Perimembranous Ventricular Septal Defect in Pediatrics.

Authors:  Mehdi Ghaderian; Mahmood Merajie; Hodjjat Mortezaeian; Moghadam Aarabi; Yoosef Mohammad; Akbar Shah Mohammadi
Journal:  Iran J Pediatr       Date:  2015-04-18       Impact factor: 0.364

7.  Directly ventricular septal defect closure without using arteriovenous wire loop: Our adult case series using transarterial retrograde approach.

Authors:  Nihat Pekel; Ertuğrul Ercan; Mehmet Emre Özpelit; Ferhat Özyurtlu; Akar Yılmaz; Caner Topaloğlu; Serkan Saygı; Serkan Yakan; İstemihan Tengiz
Journal:  Anatol J Cardiol       Date:  2017-02-21       Impact factor: 1.596

8.  Transcatheter Closure of Perimembranous Ventricular Septal Defects Using Different Generations of Amplatzer Devices: Multicenter Experience.

Authors:  Roberto Mijangos-Vázquez; Amal El-Sisi; Juan P Sandoval Jones; José A García-Montes; Rogelio Hernández-Reyes; Rodina Sobhy; Antoine Abdelmassih; Mohammed M Soliman; Safaa Ali; Tatiana Molina-Sánchez; Carlos Zabal
Journal:  J Interv Cardiol       Date:  2020-02-21       Impact factor: 2.279

9.  Influence of percutaneous catheter intervention for congenital perimembranous ventricular septal defects in children on the cardiac conduction system and associated risk factors: a meta-analysis.

Authors:  Yu-Qing Lei; Wen-Hao Lin; Shi-Hao Lin; Wen-Peng Xie; Jian-Feng Liu; Qiang Chen; Hua Cao
Journal:  J Cardiothorac Surg       Date:  2022-02-16       Impact factor: 1.637

10.  The hybrid perventricular closure of apical muscular ventricular septal defect with Amplatzer duct occluder.

Authors:  Soo Jin Kim; June Huh; Jin Young Song; Ji-Hyuk Yang; Tae-Gook Jun; I-Seok Kang
Journal:  Korean J Pediatr       Date:  2013-04-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.